Previous reports have suggested that plasma levels of FLT3LG can be used as predictor of hematological disease in GATA2 deficiency, and used in clinical monitoring post-HSCT [25]. This evidence concerns the gene FLT3LG and hyperinsulinemic hypoglycemia, familial, 4.